Anhui FDA To Question Pharma Heads In Severe Quality, Safety Cases
This article was originally published in PharmAsia News
Executive Summary
Anhui FDA recently introduced the Anhui Pharma Manufacturer Discussion System, which requires regulator talks with pharma heads in the event of severe quality and safety concerns to tackle problems at the source.